Ikhowudi yeoyile yesibindi

Umxholo

• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

Ioyile yesibindi ye-cod inokufumaneka ngokutya isibindi esitsha secod okanye ngokuthatha izongezo.

I-oyile yesibindi se-cod isetyenziswa njengomthombo wevithamini A kunye nevithamin D. Isetyenziswa njengomthombo wamanqatha abizwa ngokuba yi-omega-3 yempilo yentliziyo, ukudakumba, isifo samathambo kunye nezinye iimeko, kodwa abukho ubungqina benzululwazi obulungileyo nakuphi na ukusetyenziswa .

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe I-COD YOKUPHILA NGE-COD zezi zilandelayo:

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Isifo samehlo esikhokelela kwilahleko yombono kubantu abadala (imeko enxulumene nobudala be-macular degeneration okanye i-AMD). Abantu abatya iintlanzi ezininzi kwaye bathathe ioyile yesibindi se-cod abanamngcipheko uphantsi wokukhula kwale meko xa kuthelekiswa nabantu abatya nje iintlanzi ezininzi.
• Yewena mkhuhlane. Ukuthatha ioyile yesibindi se-cod ngexesha lokukhulelwa okanye xa uncancisa, okanye ukunika ioyile yesibindi se-cod kusana ukuya kuthi ga kwiminyaka emi-2 ubudala, kubonakala ngathi ayiyithinteli ifiva.
• Ukubetha kwentliziyo ngokungaqhelekanga (arrhythmia). Ukuthatha ioyile yesibindi ngomlomo kunokunciphisa uhlobo oluthile lokubetha kwentliziyo okungaqhelekanga kwabanye abantu. Kodwa akwaziwa ukuba oku kunciphisa umngcipheko wokufa okuhambelana nentliziyo. Ukuthatha ioyile yesibindi ngomlomo akubonakali ngathi kunciphisa ukubetha kwentliziyo okungaqhelekanga kumadoda aneentliziyo ezingafakwanga emva kohlaselo lwentliziyo.
• Isifo sombefu. Uninzi lophando lubonisa ukuba ukuthatha ioyile yesibindi se-cod ngexesha lokukhulelwa okanye ukuncancisa, okanye ukunika ioyile yesibindi ikhowudi kusana ukuya kwiminyaka emi-2 ubudala, akusithinteli isifuba. Kodwa ukuthatha ioyile yesibindi i-1-3 amaxesha ngeveki ngexa lokukhulelwa kunokunciphisa umngcipheko wesifuba emntwaneni eneminyaka emi-6 ubudala.
• I-eczema (i-atopic dermatitis). Uninzi lophando lubonisa ukuba ukuthatha ioyile yesibindi se-cod ngexesha lokukhulelwa okanye ukuncancisa, okanye ukunika ioyile yesibindi ikhowudi kusana ukuya kwiminyaka emi-2 ubudala, ayikuthinteli i-eczema. Kodwa zimbalwa iintsana ezine-eczema kunyaka omnye ubudala ukuba zithatha ioyile yesibindi ubuncinci amaxesha amane ngeveki.
• Uxinzelelo. Ukuthatha ioyile yesibindi ye-cod kunxulunyaniswe ne-29% yamathuba asezantsi kubantu abadala abaneempawu zokudakumba.
• Seswekile. Ukuthatha ioyile yesibindi kunokunceda ukulawula iswekile yegazi kubantu abanesifo seswekile ngexesha lokukhulelwa. Oku kunokukunceda ukukhusela iingxaki ngexesha lokuzalwa. Kungathatha ukuya kwiiveki ezili-12 ukuze ufumane uncedo. Ukuthatha ioyile yesibindi i-cod akubonakali kunceda kulawulo lweswekile egazini kubantu abanesifo seswekile 1.
• Ukutyekela kwilifa lokuya kwi-cholesterol ephezulu (usapho lwe-hypercholesterolemia). Uphando lwakwangoko lubonisa ukuba ukuthatha ioyile yesibindi i-cod akubonakali ngathi kunciphisa amanqanaba e-cholesterol kubantu abane-hypercholesterolemia yosapho.
• Cholesterol ephezulu. Ukuthatha ioyile yesibindi ngomlomo akwehlisi amanqanaba e-cholesterol kubantu abane-cholesterol ephezulu. Kodwa inokunyusa "ukulunga" okuphezulu kwe-lipoprotein cholesterol kwinqanaba labantu abane-1 yeswekile kunye ne-cholesterol ephezulu. Kananjalo inokunciphisa amafutha egazi abizwa ngokuba yi "triglycerides" emadodeni athe ahlaselwa sisifo sentliziyo.
• Igazi elonyukayo. Ukuthatha ioyile yesibindi ngomlomo kubonakala ngathi kunciphisa uxinzelelo lwegazi kubantu abasempilweni kunye nabo banexinzelelo lwegazi. Kodwa akucaci ukuba oku kuncitshiswa kunentsingiselo yeklinikhi kubantu abane-cholesterol ephezulu kakhulu.
• Ukuvuvukala kwexesha elide (ukuvuvukala) kwindawo yokugaya (isifo sesisu okanye isifo se-IBD). Abanye abantu abanezifo zamathumbu ezivuthayo baneentlungu ezidibeneyo. Ukuthatha ioyile yesibindi kunganciphisa iintlungu ezidityanisiweyo kwabanye abantu abanale meko.
• Osteoarthritis. Ukuthatha ioyile yesibindi kunye ne-NSAID akunciphisi ukudumba kubantu abane-osteoarthritis engcono kunokuthatha i-NSAID yodwa.
• Usulelo lwendlebe (i-otitis media). Ukuthatha ioyile yesibindi kunye ne-multivitamin kunokunciphisa isidingo sokusebenzisa amayeza ukunyanga usulelo lwendlebe kubantwana abancinci malunga ne-12%.
• Usulelo lweendlela zomoya. Ukunika abantwana abancinci ioyile yesibindi kunye ne-multivitamin kubonakala ngathi kunciphisa inani lotyelelo lweofisi kagqirha kusulelo olusemoyeni.
• Isifo samathambo (RA). Ukuthatha ioyile yesibindi kunganciphisa iintlungu, ukuqina kwentsasa, kunye nokudumba kwezinye izigulana ezine-rheumatoid arthritis. Kwakhona, ukuthatha ioyile yesibindi kunye neoyile yeentlanzi kubonakala ngathi kunciphisa isidingo sokusebenzisa amayeza ukunyanga ukudumba ngokudibeneyo kubantu abakule meko.
• Ukusilela kweVitamin D. Ukuthatha ioyile yesibindi se-cod kubonakala ngathi kunyusa amanqanaba egazi ngevithamini D kwabanye abantu. Kodwa akucaci ukuba i-oyile ye-cod yesibindi inyusa i-vitamin D iye kumanqanaba aqhelekileyo kubantu abanamanqanaba asezantsi e-vitamin D.
• Iqela lokuphazamiseka kwamehlo elinokukhokelela ekuphulukaneni nombono (glaucoma).
• Ukuphendula komzimba kwesikhumba.
• Ukutsha.
• Irhashalala.
• Isifo sentliziyo.
• Iimpawu.
• Amanqanaba aphezulu amafutha abizwa ngokuba yi-triglycerides egazini (hypertriglyceridemia).
• Ukonakala kwezintso kubantu abanesifo seswekile (isifo seswekile). .
• Ukuphilisa amanxeba.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ioyile ye-cod yesibindi kwezi zinto zisetyenziswayo.

I-oyile yesibindi se-cod iqulethe "ii-acid ezinamafutha" ezithile ezithintela igazi ekunqandeni ngokulula. Ezi fatty acids zikwanciphisa iintlungu kunye nokudumba.

Xa kuthathwa ngomlomo: I-oyile yesibindi se-cod NGOKUKHUSELEKILEYO kubantu abadala abaninzi xa bethathwe ngomlomo. Inokubangela iziphumo ebezingalindelekanga kubandakanya ukubhinqa, ukuphefumla kakubi, ukubola kwentliziyo, izitulo ezikhululekileyo kunye nesicefecefe. Ukuthatha ioyile yesibindi kunye nokutya kunokuhlala kunciphisa iziphumo ebezingalindelekanga. Iidosi eziphezulu zeoyile yesibindi se cod OKUNGENZEKA UKHUSELEKILE. Banokugcina igazi lingadibani kwaye banokonyusa ithuba lokopha. Amanqanaba eVitamin A kunye nevithamin D nawo anokuba phezulu kakhulu ngeedosi eziphezulu zeoyile yesibindi.

Xa isetyenziswa eluswiniAkukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba ngaba i-oyile ye-cod yesibindi ikhuselekile okanye nokuba ziziphi na iziphumo ebezingalindelekanga ezinokuba khona.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: I-oyile yesibindi se-cod UKHUSELEKO OLUNOKWENZEKA xa isetyenziswe kwimilinganiselo enganikeli ngaphezu kokutya okucetyiswayo kwansuku zonke i-vitamin A kunye ne-vitamin D. I-oyile yesibindi seCod OKUNGENZEKA UKHUSELEKILE xa ithathwa ngesixa esikhulu. Abasetyhini abakhulelweyo okanye abancancisayo akufuneki bathathe i-cod yeoyile yesibindi ebonelela ngaphezulu kwe-3000 mcg ye-vitamin A kunye ne-100 mcg ye-vitamin D.

Abantwana: I-oyile yesibindi se-cod NGOKUKHUSELEKILEYO kuninzi lwabantwana xa luthathwa ngomlomo ngezixa ezinganikeli ngaphezu kokucetyiswa ukuba utye ivithamin A kunye novithamini D.Ioyile yesibindi yeCod OKUNGENZEKA UKHUSELEKILE xa ithathwa ngesixa esikhulu.

Seswekile: Kukho inkxalabo yokuba ioyile yesibindi okanye enye ioyile yeentlanzi inokunyusa iswekile yegazi kubantu abanesifo seswekile. Kodwa akukho phando luqinileyo luxhasa le nkxalabo. Kodwa bukhona ubungqina bokuba ioyile yesibindi inokuthi yehlise amanqanaba eswekile yegazi kwaye inyuse iswekile esehla kwiziphumo zezinye iziyobisi ezichasene neswekile. Kukho inkxalabo yokuba iswekile yegazi inokuhla kakhulu. Ukuba unesifo seswekile kwaye usebenzisa ioyile yesibindi, jonga amanqanaba eswekile yegazi ngokusondeleyo.

Iphakathi

Lumka ngale nhlanganisela.

Amayeza eswekile (iziyobisi zeAntidiabetes)

I-oyile yesibindi se-cod inokunciphisa amanqanaba eswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ukuthatha ioyile yesibindi kunye neyeza leswekile kunokubangela ukuba iswekile yegazi lakho ibe sezantsi kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.
Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-metformin (iGlucophage), i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbotide Orinase), kunye nabanye.

Amayeza oxinzelelo lwegazi oluphezulu (iziyobisi ezichasayo)

Ioyile yesibindi yeCod ibonakala ngathi inciphisa uxinzelelo lwegazi. Ukuthatha ioyile yesibindi kunye neyeza kunye noxinzelelo lwegazi kunokubangela ukuba uxinzelelo lwegazi luye phantsi kakhulu.

Amanye amayeza oxinzelelo lwegazi aphezulu abandakanya i-captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), kunye nabanye abaninzi. .

Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)

Ioyile yesibindi ye-Cod inokucothisa ukujiya kwegazi. Ukuthatha ioyile yesibindi kunye neyeza kunye nokucothisa okucothayo kunokwandisa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, abanye), dipyridamole (Persantine), ibuprofen (Advil, Motrin, abanye), naproxen (Anaprox, Naprosyn, abanye), dalteparin (Fragmin) , enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), kunye nabanye.

Iherbs kunye nezongezo ezinokunciphisa uxinzelelo lwegazi

I-oyile yesibindi se-cod inokunciphisa uxinzelelo lwegazi. Inokubanakho ukongeza uxinzelelo lwegazi ekunciphiseni iziphumo zamanye amayeza kunye nezongezo ezinciphisa uxinzelelo lwegazi. Amanye amayeza kunye nezongezo ezinokuhlisa uxinzelelo lwegazi zibandakanya i-andrographis, i-casein peptides, uzipho lwekati, coenzyme Q10, L-arginine, lycium, neting nettle, theanine, nabanye.

Iherbs kunye nezongezo ezinokunciphisa iswekile yegazi

I-oyile yesibindi se-cod inokunciphisa iswekile yegazi. Ukuba ithathwa kunye namanye amayeza kunye nezongezo ezinokunciphisa iswekile yegazi, iswekile yegazi inokuba sezantsi kakhulu kwabanye abantu. Amanye amayeza kunye nezongezo ezinokunciphisa iswekile yegazi zibandakanya i-alpha-lipoic acid, i-melon ekrakra, i-chromium, uzipho lukaSathana, i-fenugreek, igalikhi, i-guar gum, i-chestnut yehashe, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, nezinye.

Iherbs kunye nezongezo ezinokucothisa igazi

Ioyile yesibindi ye-Cod inokucothisa ukujiya kwegazi. Sebenzisa ioyile ye-cod yesibindi ngamayeza kunye nezongezo ezithi zicothise ukucolwa kwegazi kunokunyusa amathuba okugruzuka nokopha kwabanye abantu. Ezi zityalo zibandakanya i-angelica, i-borage seed oil, i-clove, i-danshen, i-garlic, i-ginger, i-ginkgo, i-clover ebomvu, i-turmeric, i-willow kunye nabanye.

Akukho kunxibelelana kwaziwayo nokutya.

Idosi efanelekileyo yeoyile yesibindi ye-cod ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi zeoyile yesibindi. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa. Aceite de Higado de Bacalao, Acides Gras Oméga 3, Acides Gras N-3, Acides Gras Polyinsaturés, Cod Oil, Fish Liver Oil, Fish Oil, Halibut Liver Oil, Huile de Foie, Huile de Foie de Flétan, Huile de Foie de Morue , Huile de Foie de Poisson, Huile de Morue, Huile de Poisson, Liver Oil, N-3 Fatty Acids, Omega 3, Oméga 3, Omega 3 Fatty Acids, Omega-3, Omega-3 Fatty Acids, Polyunsaturated Fatty Acids.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UConus N, uBurgher-Kennedy N, van den Berg F, uKaur Datta G. Uvavanyo olungenamlinganiso ngokuthelekisa amanqanaba e-omega-3 e-fatty acid amanqanaba emva kokufakwa kweefom yeoyile yesibindi ye-cod. I-Curr Med Res Opin. Ngo-2019; 35: 587-593. Jonga i-abstract.
2. Øien T, Schjelvaag A, Storrø O, uJohnsen R, uSimpson MR. Ukusetyenziswa kweentlanzi kunyaka omnye ubudala kunciphisa umngcipheko we-eczema, i-asthma kunye ne-wheeze kwiminyaka emithandathu ubudala. Izondlo. 2019; 11. IPH: E1969. Jonga i-abstract.
3. UYang S, uLin R, uSi L, et al. Ioyile yesibindi seCod iphucula ii-indices ze-metabolic kunye ne-hs-CRP kumanqanaba okufumana isifo seswekile. J Isifo seSwekile. Ngo-2019; 2019: 7074042. Jonga i-abstract.
4. IHelland IB, iSaarem K, iSaugstad OD, iDrevon CA. Ukwenziwa kwe-asidi enamafutha kubisi loomama kunye neplasma ngexesha lokongezwa kweoyile yesibindi. I-Eur J yeKlinikhi yeNutr 1998; 52: 839-45. Jonga i-abstract.
5. UBartolucci G, uGiocaliere E, uBoscaro F, et al. Isiseko Ubungakanani beVitamin D3 kwisongezelelo esisekwe kwioyile yesibindi. J Uhlalutyo lweBi Biomed 2011; 55: 64-70. Jonga i-abstract.
6. ILinday LA. I-oyile yesibindi se-Cod, abantwana abancinci, kunye nosulelo oluphezulu lokuphefumla. J NdinguColl Nutrr 2010; 29: 559-62. Jonga i-abstract.
7. Olafsdottir AS, Thorsdottir I, Wagner KH, Elmadfa I. Polyunsaturated fatty acids ekutyeni nakubisi lwebele lwabasetyhini abancancisayo base-Iceland abaneentlanzi zemveli kunye nokusetyenziswa kweoyile yesibindi. UAnn Nutrab Metab 2006; 50: 270-6. Jonga i-abstract.
8. IHelland IB, iSaugstad OD, iSaarem K, et al. Ukongezwa kwe-n-3 fatty acids ngexesha lokukhulelwa kunye nokuncancisa kunciphisa amanqanaba eeplasma yomama kunye nokubonelela nge-DHA kwiintsana. J Maternal Fetal Neonatal Med 2006; 19: 397-406. Jonga i-abstract.
9. UFoti C, uBonamonte D, uConserva A, uPepe ML, uAngelini G.Ukuqhakamshelana ne-dermatitis kwi-cod yeoyile yesibindi equlethwe kwioli yamafutha. Nxibelelana neDermatitis 2007; 57: 281-2. Jonga i-abstract.
10. UMavroeidi A, uAucott L, uMnyama AJ, et al. Ukwahluka kwamaxesha kwi-25 (OH) D eAberdeen (57 ° N) kunye nezalathi zempilo yethambo- ngaba iiholide elangeni kunye ne-cod yesoyile yongeze ukunciphisa ukusilela? I-PLoS enye ngo-2013; 8: e53381. Jonga i-abstract.
11. I-Eysteinsdottir T, iHalldorsson TI, iThorsdottir I, okqhubekayo. Ukusetyenziswa kweoyile yesibindi ngamaxesha ahlukeneyo obomi kunye nokuxinana kwamaminerali ebudaleni. Br J Nutriti 2015; 114: 248-56. Jonga i-abstract.
12. IHardarson T, Kristinsson A, Skúladóttir G, Asvaldsdóttir H, Snorrason SP. Ioyile yesibindi ye-cod ayinciphisi ii-ventricular extrasystoles emva kwesifo se-myocardial infarction. J Ngaphakathi Med 1989; 226: 33-7. Jonga i-abstract.
13. ISkúladóttir GV, uGudmundsdóttir E, uOlafsdóttir E, et al. Isiseko Impembelelo yeoyile yesibindi yokutya kwi-fatty acid ekwakhiweni kweeplasma lipids kwizifundo ezingamadoda emva kokuhlaselwa sisifo sephepha. J Ngaphakathi kwe1990; 228: 563-8. Jonga i-abstract.
14. UGruenwald J, Graubaum HJ, Harde A. Iziphumo zeoyile yesibindi kwiimpawu zesifo samathambo. Ugqwetha 2002; 19: 101-7. Jonga i-abstract.
15. ILinday LA, iShindledecker RD, iTapia-Mendoza J, iDolitsky JN. Iziphumo zeoyile yesibindi yekhowudi yemihla ngemihla kunye nesongezelelo se-multivitamin-multimineral kunye ne-selenium kwindlela ephezulu yokuphefumla ukutyelelwa kwabantwana ngabantu abancinci, abangaphakathi-dolophu, abantwana baseLatino: iisayithi zabantwana ezingenamntu. UAnn Otol Rhinol Laryngol 2004; 113: 891-901. Jonga i-abstract.
16. IPorojnicu AC, Bruland OS, Aksnes L, Brant WB, Moan J.Iibhedi zelanga kunye ne-oyile ye-cod yesibindi njengemithombo ye-vitamin D. J Photochem Photobiol B Biol 2008; 91: 125-31. Jonga i-abstract.
17. IBrunborg LA, iMadland TM, iLind RA, et al. Iziphumo zolawulo lwexeshana lomlomo lweoyile yaselwandle yokutya kwizigulana ezinesifo sokukrala kwamathumbu kunye nentlungu edibeneyo: isifundo somqhubi ngokuthelekisa ioyile yesitywina kunye neoyile yesibindi. Iiklinikhi zeNutr 2008; 27: 614-22. Jonga i-abstract.
18. UJonasson F, uFisher DE, uEiriksdottir G, et al. Iminyaka emihlanu yezehlo, ukuqhubela phambili, kunye nemingcipheko yokuchaphazeleka okunxulumene nobudala be-macular: ubudala, isifundo semfuza / imeko yokusingqongileyo. Ophthalmology 2014; 121: 1766-72. Jonga i-abstract.
19. IMay XM, iLanghammer A, Chen Y, iCamargo CA. Ukutya ioyile yesibindi kunye nezehlo zesifuba kubantu abadala baseNorway-isifundo se-HUNT. I-Thorax 2013; 68: 25-30. Jonga i-abstract.
20. I-Detopoulou P, iPapamikos V. Ukopha emathunjini emva kokutya okuphezulu kwe-omega-3 fatty acids, i-cortisone kunye nonyango lwe-antibiotiki: ityala lokufunda. I-Int J yezeMidlalo yokuSebenza yeNutrab 2014; 24: 253-7. Jonga i-abstract.
21. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (ii-eds). Ukufakwa kwereferensi yokutya kwi-calcium kunye novithamini D. IZiko lezeMithi, ngo-2011. .
22. U-Ahmed AA, uHolub BJ. Utshintsho kunye nokubuyiselwa kwamaxesha okuphuma kwegazi, ukuhlanganiswa kweplatelet kunye nokwenziwa kwe-asidi ye-asidi ye-phospholipids kwiiplatelets zezifundo zabantu ezifumana ukongezwa kweoyile yesibindi. IiLipids ngo-1984; 19: 617-24. Jonga i-abstract.
23. I-Lorenz R, i-Spengler U, i-Fischer S, i-Duhm J, i-PC ye-Weber.Umsebenzi wePlatelet, ukwakheka kwe-thromboxane kunye nolawulo lwexinzelelo lwegazi ngexesha lokongezwa kokutya kweNtshona nge-cod yeoyile yesibindi. Ukujikeleza kwe1983; 67: 504-11. Jonga i-abstract.
24. UGalarraga, B., Ho, M., Youssef, HM, Hill, A., McMahon, H., Hall, C., Ogston, S., Nuki, G., noBelch, ioyile yesibindi yeJJ Cod (n-3 fatty acids) njenge-non-steroidal anti-inflammatory drug arhente kwi-rheumatoid arthritis. Rheumatology. (Oxford) 2008; 47: 665-669. Jonga i-abstract.
25. URaeder MB, uSeen VM, uVollset SE, uBjelland I. Unxibelelwano phakathi kokusetyenziswa kweoyile yesibindi kunye neempawu zoxinzelelo: Isifundo sezeMpilo seHordaland. J Ukuchaphazela ukungaboni ngasonye 2007; 101: 245-9. Jonga i-abstract.
26. Umfama u-A, uMontori V, uDinneen S, uClar C. Ioyile yeentlanzi kubantu abane-2 yesifo seswekile. Isiseko sedatha yeCochrane Sy Rev Rev 2001; 3: CD003205. Jonga i-abstract.
27. ILinday LA, iDolitsky JN, iShindledecker RD, iPippenger CE. Ioyile enencasa yeLemon kunye ne-multivitamin-mineral mineral yokuthintela okwesibini i-otitis media kubantwana abancinci: uphando lokulinga. UAnn Otol Rhinol Laryngol 2002: 111: 642-52 .. Jonga i-abstract.
28. U-Brox JH, uKillie JE, u-Osterud B, et al. Iziphumo zeoyile yesibindi secod kwiiplatelets kunye nokuxinana kwi-hypercholesterolemia yosapho (uhlobo IIa). I-Acta Med Scand 1983; 213: 137-44 .. Jonga i-abstract.
29. ILandymore RW, iMacAulay MA, iCooper JH, iSheridan BL. Iziphumo zeoyile yesibindi se-cod kwi-hyperplasia ye-intimal kwimithambo ye-vein esetyenziselwa ukudlula kwimithambo. Ngaba uJ Surg 1986; 29: 129-31 .. Jonga i-abstract.
30. i-al-Meshal MA, i-Lutfi KM, i-Tariq M. Cod yeoyile yesibindi inqanda i-indomethacin inyanzelisa isisu ngaphandle kokuchaphazela ukungafumaneki kwayo kunye nomsebenzi we-pharmacological. Ubomi beSayensi ngo-1991; 48: 1401-9 .. Jonga i-abstract.
31. UHansen JB, u-Olsen JO, uWilsgard L, u-Osterud B. Iziphumo zokutya okuneoli kunye neoyile yesibindi kwi-monocyte thromboplastin synthesis, coagulation kunye ne-fibrinolysis. J Intern Med Suppl 1989; 225: 133-9 .. Jonga i-abstract.
32. UAviram M, uBrox J, uNordoy A. Iziphumo zeplasma yangaphambi kweprandial kunye ne-chylomicrons kwiiseli ze-endothelial. Umahluko phakathi kwekhrimu yokutya kunye neoyile yesibindi secod. I-Acta Med Scand 1986; 219: 341-8 .. Jonga i-abstract.
33. Umthengisi uSermayer A, uWitzgall H, uLorenz RL, uWeber PC. Iziphumo zeoyile yentlanzi yokutya kwizakhiwo zangaphambi kwexesha. NdinguJ Cardiol 1995; 76: 974-7. Jonga i-abstract.
34. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukungeniswa kwereferensi yokutya kwiVitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, kunye neZinc. IWashington, DC: ICandelo leSizwe lezeMfundo, 2002. Iyafumaneka kwi: www.nap.edu/books/0309072794/html/.
35. ISanders TA, iVickers M, iHaines AP. Iziphumo zeepids zegazi kunye nehaemostasis yokongezwa kweoyile yesibindi, etyebile kwi-eicosapentainoic kunye ne-docosahexaenoic acid, emadodeni asempilweni. Iiklinikhi zeSci (Colch) 1981; 61: 317-24. Jonga i-abstract.
36. I-Brox JH, Killie JE, Gunnes S, Nordoy A. Iziphumo zeoyile yesibindi kunye neoyile yengqolowa kwiiplatelets kunye nodonga lweenqanawa emntwini. UTromb Haemost 1981; 46: 604-11. Jonga i-abstract.
37. ILandymore RW, iKinley CE, uCooper JH, et al. Ioyile yesibindi se-Cod kuthintelo lwe-hyperplasia ye-intem kwi-autogenous vein graft esetyenziselwa ukudlula kwimithambo. J Thorac Cardiovasc Surg 1985; 89: 351-7. Jonga i-abstract.
38. I-Landymore RW, iMacAulay M, uSheridan B, uCameron C. Thelekisa ioyile yesibindi kunye neasprini-dipyridamole yokuthintela i-hyperplasia ephezulu kwi-autologous vein graft. UAnn Thorac Surg 1986; 41: 54-7. Jonga i-abstract.
39. UHenderson MJ, uJones RG. I-oyile yesibindi se-cod okanye ukugcwala. ILancet 1987; 2: 274-5.
40. Anon. I-oyile ye-oyile yentlanzi enelayisensi xa kuthelekiswa neoyile yesibindi. ILancet 1987; 2: 453.
41. UJensen T, uStender S, uGoldstein K, et al. Ukulungelelaniswa okwahlukileyo kukutya okune-cod-isibindi seoyile yokunyuka kwe-albinvascular albumin ukuvuza kwizigulana ezinesifo seswekile esixhomekeke kwi-insulin kunye nealbininuria. U-Eng Eng J Med 1989; 321: 1572-7. Jonga i-abstract.
42. I-Stammers T, iSibbald B, i-Freeling P. Ukusebenza kweoyile yesibindi njengesihlomelo kunyango lwe-non-steroidal anti-inflammatory drug in the management of osteoarthritis in general practice. UAnn Rheum Dis 1992; 51: 128-9. Jonga i-abstract.
43. ULombardo YB, uChicco A, uD'Alessandro ME, et al. Ioyile yentlanzi yokutya ibangela ukuba i-dyslipidemia kunye nokunganyamezelani kwe-glucose ngamanqanaba e-insulin angatshintshanga kwiigundane ezondla ukutya okuphezulu kwe-sucrose. IBiochim Biophys Acta 1996; 1299: 175-82. Jonga i-abstract.
44. UDawson JK, u-Abernethy VE, uGraham DR, iLynch MP. Umfazi othathe ioyile yesibindi kunye nokutshaya. ILancet 1996; 347: 1804.
45. I-Veierod MB, i-Thelle DS, i-Laake P. Ukutya kunye nomngcipheko we-melanoma enobungozi: isifundo esinokubakho samadoda nabafazi baseNorway abangama-50,757. Int J Umhlaza 1997; 71: 600-4. Jonga i-abstract.
46. UTerkelsen LH, uEskild-Jensen A, uKjeldsen H, et al. Ukusetyenziswa kwesihloko seoyile yeoyile yesibindi kukhawulezisa ukuphilisa amanxeba: isifundo sovavanyo kumanxeba asezindlebeni zeempuku ezingenaboya. I-Scand J iPlast yokuphonononga kwakhona iSurg Hand Hand 2000; 34: 15-20. Jonga i-abstract.
47. I-FDA. Iziko loKhuseleko loKutya kunye nokuSebenza kwesondlo. Ileta emalunga nesongezelelo sokutya ibango lezempilo le-omega-3 fatty acids kunye nesifo sentliziyo. Ifumaneka kwi: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference-F-FDA-vol205.pdf. (Kufumaneka ngoFebruwari 7, 2017).
48. UShimizu H, u-Ohtani K, uTanaka Y, et al. Iziphumo zexesha elide ze-eicosapentaenoic acid ethyl (EPA-E) kwi-albinuria yezigulana ezinesifo seswekile ezingaxinisekanga kwi-insulin. Ukusebenza kwesifo seswekile ngo-1995; 28: 35-40. Jonga i-abstract.
49. UToft I, Bonaa KH, Ingebretsen OC, et al. Iziphumo ze-n-3 polyunsaturated fatty acids kwi-glucose homeostasis kunye noxinzelelo lwegazi kuxinzelelo lwegazi olufunekayo. Uvavanyo olungenamkhethe, olulawulwayo. UAnn Intern Med 1995; 123: 911-8. Jonga i-abstract.
50. UPrisco D, uPaniccia R, uBandellielli B, et al. Iziphumo zokuxhaswa kwexesha eliphakathi kunye nedosi emodareyitha ye-n-3 polyunsaturated fatty acids kuxinzelelo lwegazi kwizigulana ezinobuzaza. I-Thromb Res ngo-1998; 1: 105-12. Jonga i-abstract.
51. IGibson RA. I-chain-polyunsaturated fatty acids kunye nophuhliso lweentsana (uhlelo). ILancet 1999; 354: 1919.
52. ULucas A, uStafford M, uMorley R, et al. Ukusebenza kunye nokukhuseleka kwexesha elide le-polyunsaturated fatty acid yokuxhasa ubisi olungumgubo lweentsana: ityala elingahleliwe. ILancet 1999; 354: 1948-54. Jonga i-abstract.

Ukuhlaziywa okokugqibela-02/12/2021